EXPAREL: payments to doctors
Payments that named EXPAREL as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $27M
- Providers
- 38,364
- Transactions
- 75,067
- Average per transaction
- $360
The per-transaction average — $360 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 38,364 providers the average total is $704, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Pacira Pharmaceuticals Incorporated | $25,927,319 | 96.0% |
| Medical Device Business Services, Inc. | $1,019,978 | 3.8% |
| Depuy Synthes Products, Inc. | $29,851 | 0.1% |
| Johnson & Johnson | $28,132 | 0.1% |
| Pacira Therapeutics, Inc. | $1,166 | 0.0% |